Meng Gao
Director Financiero/CFO en Nan Fung Life Sciences .
Perfil
Prior to joining Oaktree in 2006, Mr. Meng Gao served as an Associate in the Natural Resources and Industrials Groups at J.P.
Morgan Securities in New York.
Prior to that, he was a Financial Analyst in the Mergers and Acquisitions and Retail Groups at Credit Suisse First Boston in New York.
Mr. Meng Gao received a Bachelor of Economics degree in International Finance from Peking University, an M.A.
degree in International Relations from Yale University and an M.B.A.
with honors in Finance and Entrepreneurial Management from the Wharton School at the University of Pennsylvania.
He is a native Mandarin speaker and is fluent in English.
Cargos activos de Meng Gao
Empresas | Cargo | Inicio |
---|---|---|
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Inversor de Capital Privado | - |
Nan Fung Life Sciences
Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Director Financiero/CFO | - |
Antiguos cargos conocidos de Meng Gao.
Empresas | Cargo | Fin |
---|---|---|
Oaktree Capital (Hong Kong) Ltd.
Oaktree Capital (Hong Kong) Ltd. Investment ManagersFinance Oaktree Capital (Hong Kong) Ltd. (Oaktree-Hong Kong) is the subsidiary of Oaktree Capital Management LP in the US, founded in1995 by Howard Marks, Bruce Karsh, Steve Kaplan, Larry Keele, Richard Masson and Sheldon Stone.. Established in 2005, the Hong Kong subsidiary aims to provide investment management in a limited number of specialized niche markets where they believe the potential for reward outweighs the risk. | Director/Miembro de la Junta | 31/03/2011 |
Arctic Vision (Shanghai) Biotechnology Co., Ltd.
Arctic Vision (Shanghai) Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Arctic Vision (Shanghai) Biotechnology Co., Ltd. is a Chinese Shanghai-based ophthalmic biotech company that focuses on developing innovative therapies to address unmet clinical needs and benefit ophthalmic patients. The company is led by an elite team of ophthalmic industry veterans with substantial experience in R&D and commercialization of eye care products. Arctic Vision has top-tier biotech venture capital investors with a broad network in both the U.S. and European ophthalmic markets, and an unprecedented track record in company incubation. The company was founded by Hai Di Hu, who has been the CEO since incorporation. | Inversor de Capital Privado | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Oaktree Capital (Hong Kong) Ltd.
Oaktree Capital (Hong Kong) Ltd. Investment ManagersFinance Oaktree Capital (Hong Kong) Ltd. (Oaktree-Hong Kong) is the subsidiary of Oaktree Capital Management LP in the US, founded in1995 by Howard Marks, Bruce Karsh, Steve Kaplan, Larry Keele, Richard Masson and Sheldon Stone.. Established in 2005, the Hong Kong subsidiary aims to provide investment management in a limited number of specialized niche markets where they believe the potential for reward outweighs the risk. | Finance |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Finance |
Arctic Vision (Shanghai) Biotechnology Co., Ltd.
Arctic Vision (Shanghai) Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Arctic Vision (Shanghai) Biotechnology Co., Ltd. is a Chinese Shanghai-based ophthalmic biotech company that focuses on developing innovative therapies to address unmet clinical needs and benefit ophthalmic patients. The company is led by an elite team of ophthalmic industry veterans with substantial experience in R&D and commercialization of eye care products. Arctic Vision has top-tier biotech venture capital investors with a broad network in both the U.S. and European ophthalmic markets, and an unprecedented track record in company incubation. The company was founded by Hai Di Hu, who has been the CEO since incorporation. | Health Technology |
Nan Fung Life Sciences
Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Finance |
- Bolsa de valores
- Insiders
- Meng Gao